http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113402635-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-206
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0075
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D15-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10
filingDate 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113402635-B
titleOfInvention Method for separating and purifying heparin by expanded bed countercurrent chromatography
abstract The invention relates to the technical field of heparin separation and purification, in particular to a method for separating and purifying heparin by an expanded bed countercurrent chromatography; anion exchange resin is used as a solid adsorption medium, the solid adsorption medium is added into an expanded bed countercurrent chromatography separation column, and a heparin solution is loaded to the expanded bed countercurrent chromatography for adsorption, elution, alcohol precipitation, centrifugation and washing to obtain purified heparin. The invention adds the solid separation medium commonly used in the fixed bed column chromatography into the separation column of the countercurrent chromatography, and forms the state of the expansion and dispersion of the adsorption medium in the separation column based on the countercurrent chromatography fluid dynamics balance principle to construct the expanded bed countercurrent chromatography, which can be used as a novel chromatographic separation method for separating polar polysaccharide heparin drugs. The method has the advantages of high sample processing amount, remarkably improved utilization rate of the adsorption medium, and good application prospect in separation and purification of polar polysaccharide bioactive macromolecules.
priorityDate 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103122018-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451745990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID772
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492895

Total number of triples: 34.